Life-threatening 5-fluorouracil-like cardiac toxicity after treatment with 5-fluorocytosine.
Isetta
C
C
Hôpital Pasteur and Centre Antoine-Lacassagne, Nice, France.
Garaffo
R
R
Bastian
G
G
Jourdan
J
J
Baudouy
M
M
Milano
G
G
D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy; D002303:Cardiac Output, Low / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004452:Echocardiography; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D005437:Flucytosine / Q000009:adverse effects* / Q000627:therapeutic use; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D017583:Hemodiafiltration; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D013318:Stroke Volume / Q000187:drug effects; D013997:Time Factors
D000935:Antifungal Agents; D002316:Cardiotonic Agents; D005437:Flucytosine